Association analysis of glycine- and serine-related genes in a Japanese population of patients with schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 3, 2009, Pages 511-518

  Ohnuma, Tohru ^a   Shibata, Nobuto ^a   Maeshima, Hitoshi ^a   Baba, Hajime ^a   Hatano, Tokiko ^a   Hanzawa, Ryo ^a   Arai, Heii ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DAO; Glutamate; Polymorphism; Schizophrenia; Serine

Indexed keywords

GENOMIC DNA; GLYCINE; SERINE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DAO GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; SCHIZOPHRENIA;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; D-AMINO-ACID OXIDASE; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLYCINE; GLYCINE HYDROXYMETHYLTRANSFERASE; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHOSPHOGLYCERATE DEHYDROGENASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RACEMASES AND EPIMERASES; SCHIZOPHRENIA; SERINE; YOUNG ADULT;

EID: 62849107255     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.02.004     Document Type: Article

References (24)

1. Arinami T., Ohtsuki T., Ishiguro H., Ujike H., Tanaka Y., and Morita Y. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet 77 (2005) 937-944
2. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., et al. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 99 (2002) 13675-13680
3. Cordell H.J., and Clayton D.G. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 70 (2002) 124-141
4. Corvin A., McGhee K.A., Murphy K., Donohoe G., Nangle J.M., Schwaiger S., et al. Evidence for association and epistasis at the DAOA/G30 and d-amino acid oxidase loci in an Irish schizophrenia sample. Am J Med Genet B Neuropsychiatr Genet 144 (2007) 949-953
5. Evins A.E., Amico E., Posever T.A., Toker R., and Goff D.C. d-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia. Schizophr Res 56 (2002) 19-23
6. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders. Biometrics Research Department, New York State Psychiatric Institute (1995), New York
7. Fujii K., Maeda K., Hikida T., Mustafa A.K., Balkissoon R., Xia J., et al. Serine racemase binds to PICK1: potential relevance to schizophrenia. Mol Psychiatry 11 (2006) 150-157
8. Hashimoto A., Nishikawa T., Konno R., Niwa A., Yasumura Y., Oka T., et al. Free d-serine, d-aspartate and d-alanine in central nervous system and serum in mutant mice lacking d-amino acid oxidase. Neurosci Lett 152 (1993) 33-36
9. Hashimoto K., Engberg G., Shimizu E., Nordin C., Lindstrom L.H., and Iyo M. Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 767-769
10. Hashimoto K., Fukushima T., Shimizu E., Komatsu N., Watanabe H., Shinoda N., et al. Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 60 (2003) 572-576
11. Heresco-Levy U., Javitt D.C., Ermilov M., Mordel C., Silipo G., and Lichtenstein M. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry. 56 (1999) 29-36
12. Liu X., He G., Wang X., Chen Q., Qian X., Lin W., et al. Association of DAAO with schizophrenia in the Chinese population. Neurosci Lett 369 (2004) 228-233
13. Morikawa A., Hamase K., Inoue T., Konno R., Niwa A., and Zaitsu K. Determination of free d-aspartic acid, d-serine and d-alanine in the brain of mutant mice lacking d-amino acid oxidase activity. J Chromatogr B Biomed Sci Appl 757 (2001) 119-125
14. Morita Y., Ujike H., Tanaka Y., Otani K., Kishimoto M., Morio A., et al. A genetic variant of the serine racemase gene is associated with schizophrenia. Biol Psychiatry 61 (2007) 1200-1203
15. Ohnuma T., Sakai Y., Maeshima H., Hatano T., Hanzawa R., Abe S., et al. Changes in plasma glycine, l-serine, and d-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP). Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1905-1912
16. Schumacher J., Jamra R.A., Freudenberg J., Becker T., Ohlraun S., Otte A.C., et al. Examination of G72 and d-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 9 (2004) 203-207
17. Shi J., Gershon E.S., and Liu C. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res 104 (2008) 96-107
18. Shinkai T., De Luca V., Hwang R., Muller D.J., Lanktree M., Zai G., et al. Association analyses of the DAOA/G30 and d-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia. Neuromolecular Med 9 (2007) 169-177
19. Tsai G., Yang P., Chung L.C., Lange N., and Coyle J.T. d-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry. 44 (1998) 1081-1089
20. Tsai G., Lane H.Y., Yang P., Chong M.Y., and Lange N. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry. 55 (2004) 452-456
21. Waziri R., Baruah S., Hegwood T.S., and Sherman A.D. Abnormal serine hydroxymethyl transferase activity in the temporal lobes of schizophrenics. Neurosci Lett 120 (1990) 237-240
22. Waziri R., Baruah S., and Sherman A.D. Abnormal serine-glycine metabolism in the brains of schizophrenics. Schizophr Res 8 (1993) 233-243
23. Wood L.S., Pickering E.H., and Dechairo B.M. Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biol Psychiatry 61 (2007) 1195-1199
24. Yamada K., Ohnishi T., Hashimoto K., Ohba H., Iwayama-Shigeno Y., Toyoshima M., et al. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels. Biol Psychiatry 57 (2005) 1493-1503